| * Even Flow |
| * Differential Antiatherogenic Effects of PPAR Versus PPAR Agonists |
| * A Mouse Model of the Perimenopausal Transition |
| * Atherosclerosis in Patients With Autoimmune Disorders |
| * Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine |
| * Heme Oxygenase and Atherosclerosis |
| * Rapid Effects of Rosiglitazone Treatment on Endothelial Function and Inflammatory Biomarkers |
| * Vascular Endothelium Has a Local Anti-Adenovirus Vector System and Glucocorticoid Optimizes Its Gene Transduction |
| * Shear Stress Induces Endothelial Differentiation From a Murine Embryonic Mesenchymal Progenitor Cell Line |
| * Peroxisome Proliferator-Activated Receptor Ligands Stimulate Endothelial Nitric Oxide Production Through Distinct Peroxisome Proliferator-A |
| * Caveolin-1 Is Essential for Activation of Rac1 and NAD(P)H Oxidase After Angiotensin II Type 1 Receptor Stimulation in Vascular Smooth Muscl |
| * Pentraxin 3 Inhibits Fibroblast Growth Factor 2–Dependent Activation of Smooth Muscle Cells In Vitro and Neointima Formation In Vivo |
| * Signal-Crosstalk Between Rho/ROCK and c-Jun NH2-Terminal Kinase Mediates Migration of Vascular Smooth Muscle Cells Stimulated by Angiotensin |
| * CD34+ Cells Home, Proliferate, and Participate in Capillary Formation, and in Combination With CD34– Cells Enhance Tube Formation in a 3-Dim |
| * Identification and Characterization of Vascular Calcification–Associated Factor, a Novel Gene Upregulated During Vascular Calcification In V |
| * Mast Cell Tryptase in Mast Cell Granules Enhances MCP-1 and Interleukin-8 Production in Human Endothelial Cells |
| * Mechanisms of the Inhibitory Effect of Epigallocatechin-3-Gallate on Cultured Human Vascular Smooth Muscle Cell Invasion |
| * Critical Role of Mst1 in Vascular Remodeling After Injury |
| * Important Role of Apoptosis Signal-Regulating Kinase 1 in Ischemia-Induced Angiogenesis |
| * Aldehyde Dehydrogenase 2 Plays a Role in the Bioactivation of Nitroglycerin in Humans |
| * Heparin-Binding Epidermal Growth Factor–Like Growth Factor, Collateral Vessel Development, and Angiogenesis in Skeletal Muscle Ischemia |
| * Overexpression of Human Apolipoprotein A-II in Transgenic Mice Does Not Impair Macrophage-Specific Reverse Cholesterol Transport In Vivo |
| * Overexpression of Human Apolipoprotein A-II in Transgenic Mice Does Not Impair Macrophage-Specific Reverse Cholesterol Transport In Vivo |
| * PPAR, but not PPAR, Activators Decrease Macrophage-Laden Atherosclerotic Lesions in a Nondiabetic Mouse Model of Mixed Dyslipidemia |
| * Rosiglitazone Attenuates Atherosclerosis in a Model of Insulin Insufficiency Independent of Its Metabolic Effects |
| * Atherosclerotic Lesion Development in a Novel Ovary-Intact Mouse Model of Perimenopause |
| * Genetic Deletion or Antibody Blockade of 1?1 Integrin Induces a Stable Plaque Phenotype in ApoE–/– Mice |
| * Association Between Prostaglandin E Receptor Subtype EP4 Overexpression and Unstable Phenotype in Atherosclerotic Plaques in Human |
| * An Oral ApoJ Peptide Renders HDL Antiinflammatory in Mice and Monkeys and Dramatically Reduces Atherosclerosis in Apolipoprotein E–Null Mice |
| * Cytoplasmic Expression and Extracellular Deposition of an Antiangiogenic Factor, Pigment Epithelium-Derived Factor, in Human Atherosclerotic |
| * Tendon Xanthomas in Familial Hypercholesterolemia Are Associated With Cardiovascular Risk Independently of the Low-Density Lipoprotein Recep |
| * Effects of Diet and Simvastatin on Fatty Acid Composition in Hypercholesterolemic Men |
| * Cytosolic Lipid Droplets Increase in Size by Microtubule-Dependent Complex Formation |
| * Relationship of Monocyte Count and Peripheral Arterial Disease |
| * Hepatic and Cardiovascular Consequences of Familial Hypobetalipoproteinemia |
| * The Molecular Basis of Lecithin:Cholesterol Acyltransferase Deficiency Syndromes |
| * Familial Combined Hyperlipidemia in Mexicans |
| * Recurrence Rate After a First Venous Thrombosis in Patients With Familial Thrombophilia |
| * Protective Mechanisms of Inosine in Platelet Activation and Cerebral Ischemic Damage |
| * Endogenous NO Blockade Enhances Tissue Factor Expression via Increased Ca2+ Influx Through MCP-1 in Endothelial Cells by Monocyte Adhesion |
| * Consequences of Cholesteryl Ester Transfer Protein Inhibition in Patients With Familial Hypoalphalipoproteinemia |
| * Toll-Like Receptors, Endocrine Stress Response, and Arteriosclerosis |
| * Lipopolysaccharide (LPS) Contamination Plays the Real Role in C-Reactive Protein–Induced IL-6 Secretion From Human Endothelial Cells In Vitr |
| * Association of C-Reactive Protein With Blood Pressure |